Zim Laboratories Ltd.
Snapshot View

332.00 +8.65 ▲2.7%

25 November 2022, 04:01:00 PM
Volume: 7,997

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zimlab.in
Market Cap 546.38 Cr.
Enterprise Value(EV) 600.67 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 13.36 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 24.85 Trailing Twelve Months Ending 2022-09
Industry PE 35.02 Trailing Twelve Months Ending 2022-09
Book Value / Share 115.33 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.88 Calculated using Price: 332.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.62 Cr. 16,241,938 Shares
FaceValue 10
Company Profile
The company is engaged in the manufacturing of formulation on drugs and pre formulation on ingredients in India and marketing and selling these within and outside India.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.68%
1 Week
-10.16%
1 Month
+33.39%
3 Month
+56.27%
6 Month
+35.21%
1 Year
+175.18%
2 Year
+272.62%
5 Year
10 Year
8 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -22.94 5.29 17.21 15.07 10.73 2.17 4.66 8.65
Return on Capital Employed (%) -8.70 9.95 14.20 16.46 14.64 5.39 8.70 12.52
Return on Assets (%) -8.12 1.95 7.33 7.02 4.93 1.02 2.28 4.37

Balance Sheet View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 94 99 118 137 151 154 161 176 187
Non Curr. Liab. 38 35 18 17 20 23 19 20 24
Curr. Liab. 134 124 113 141 156 143 142 147 132
Minority Int.
Equity & Liab. 266 257 250 295 328 320 322 343 344
Non Curr. Assets 97 102 96 122 132 138 130 129 134
Curr. Assets 169 155 154 173 195 182 192 214 210
Misc. Exp. not W/O
Total Assets 266 257 250 295 328 320 322 343 344

Profit Loss View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 266 269 235 273 335 278 307 333 384
Other Income 2 4 6 3 2 5 2 4 6
Total Income 269 272 241 276 337 282 310 338 390
Total Expenditure -245 -239 -204 -238 -293 -255 -268 -292 -335
PBIDT 24 33 37 38 44 27 42 45 55
Interest -10 -14 -10 -9 -11 -13 -11 -8 -6
Depreciation -7 -9 -9 -10 -11 -14 -16 -16 -17
Taxation 5 0 1 -6 -7 3 -3 -6 -10
Exceptional Items -33 -5 6 -5
PAT -22 5 19 19 15 3 7 15 22
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -22 5 19 19 15 3 7 15 22
Adjusted EPS -14 3 12 12 10 2 5 9 13

Cash Flow View Details >>

Particulars 8 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 6 22 32 37 35 22 32 49
Cash Fr. Inv. -9 -12 -7 -26 -21 -19 -6 -15
Cash Fr. Finan. -3 -10 -25 -10 -15 -2 -26 -33
Net Change -7 0 0 1 -1 0 2
Cash & Cash Eqvt 1 1 0 1 1 1 1 3

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 33.26 33.26 33.26 33.26 33.26 33.26 33.26 33.26 33.26
Public 66.74 66.74 66.74 66.74 66.74 66.74 66.74 66.74 66.74
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 25 Nov 2022
Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to inform you that the Company has successfully listed its shares on the National Stock Exchange of India Limited (NSE) Main Board on 25th November 2022.
Fri, 25 Nov 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per the Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 RTA has received request from the shareholder for issue of Duplicate Share Certificates and accordingly RTA of the Company has marked stop transfer until Duplicate Share Certificates are issued.
Thu, 24 Nov 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per the Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 RTA has received request from the shareholder for issue of Duplicate Share Certificates and accordingly RTA of the Company has marked stop transfer until Duplicate Share Certificates are issued.

Technical Scans View Details >>

Fri, 25 Nov 2022
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Entering 52 Week High Zone Close Entering 52 Week High Zone
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On Zim Laboratories Ltd.

What is Zim Laboratories share price?

Can I buy Zim Laboratories shares now?

What is the Market Cap of Zim Laboratories?

What are the key metrics to analyse Zim Laboratories?